The global Low Molecular Weight Heparin API market was valued at US$ 1049 million in 2023 and is anticipated to reach US$ 1858 million by 2030, witnessing a CAGR of 12.3% during the forecast period 2024-2030.

Low Molecular Weight Heparin API Market

Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the low molecular weight heparin API.

The Low Molecular Weight Heparin (LMWH) API market plays a crucial role in the global pharmaceutical industry due to the widespread use of LMWHs in the prevention and treatment of blood clot-related disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). LMWH APIs are preferred in clinical settings for their favorable pharmacological properties, including better bioavailability, longer half-life, and reduced risk of side effects compared to unfractionated heparin. The increasing prevalence of cardiovascular diseases and venous thromboembolism, aging populations, and a rise in surgical procedures worldwide have significantly driven demand for LMWH-based therapies.

The North American and European markets lead in demand due to a high prevalence of thrombosis-related conditions and advanced healthcare infrastructure. Asia-Pacific is emerging as a growth market, driven by increased healthcare spending and the rise of generics. North American market for Low Molecular Weight Heparin API was valued at $ 316.04 million in 2023 and will reach $ 562.16 million by 2030, at a CAGR of 12.54% during the forecast period of 2024 through 2030. Asia-Pacific market for Low Molecular Weight Heparin API was valued at $ 389.01 million in 2023 and will reach $ 716.75 million by 2030, at a CAGR of 12.88% during the forecast period of 2024 through 2030. Europe market for Low Molecular Weight Heparin API was valued at $ 330.87 million in 2023 and will reach $ 559.93 million by 2030, at a CAGR of 11.45% during the forecast period of 2024 through 2030.

Low Molecular Weight Heparin API segment market, the Enoxaparin Sodium holds an important share, and it is expected to reach a value of US$ 1,258.82 million by 2030, at a CAGR of 12.46% during 2024 and 2030.

The global key companies of Low Molecular Weight Heparin API include Yantai Dongcheng Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Pfizer, Nanjing King-friend Biochemical Pharmaceutical, Changzhou Qianhong Biopharma, and Qingdao Jiulong Biopharmaceutical, etc. In 2023, the global five largest players hold a share approximately 68.81% in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Low Molecular Weight Heparin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Low Molecular Weight Heparin API.

The Low Molecular Weight Heparin API market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Low Molecular Weight Heparin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Low Molecular Weight Heparin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Low Molecular Weight Heparin API Market Report

Report Metric	Details
Report Name	Low Molecular Weight Heparin API Market
Accounted market size in 2023	US$ 1049 million
Forecasted market size in 2030	US$ 1858 million
CAGR	12.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Low Molecular Weight Heparin Sodium Low Molecular Weight Heparin Calcium
Segment by Application	Enoxaparin Sodium Nadroparin Calcium Dalteparin Sodium Tinzaparin Sodium Parnaparin Sodium
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Yantai Dongcheng Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Pfizer, Nanjing King-friend Biochemical Pharmaceutical, Changzhou Qianhong Biopharma, Qingdao Jiulong Biopharmaceutical, Dongying Tiandong Pharmaceutical, Yino Pharma, Opocrin, Hebei Changshan Biochemical Pharmaceutical, Hubei Enoray Biopharmaceutical, Nanjing Nanda Pharmaceutical, Cisen Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Low Molecular Weight Heparin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Low Molecular Weight Heparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Low Molecular Weight Heparin API Market growing?

Ans: The Low Molecular Weight Heparin API Market witnessing a CAGR of 12.3% during the forecast period 2024-2030.

What is the Low Molecular Weight Heparin API Market size in 2030?

Ans: The Low Molecular Weight Heparin API Market size in 2030 will be US$ 1858 million.

Who are the main players in the Low Molecular Weight Heparin API Market report?

Ans: The main players in the Low Molecular Weight Heparin API Market are Yantai Dongcheng Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Pfizer, Nanjing King-friend Biochemical Pharmaceutical, Changzhou Qianhong Biopharma, Qingdao Jiulong Biopharmaceutical, Dongying Tiandong Pharmaceutical, Yino Pharma, Opocrin, Hebei Changshan Biochemical Pharmaceutical, Hubei Enoray Biopharmaceutical, Nanjing Nanda Pharmaceutical, Cisen Pharmaceutical

What are the Application segmentation covered in the Low Molecular Weight Heparin API Market report?

Ans: The Applications covered in the Low Molecular Weight Heparin API Market report are Enoxaparin Sodium, Nadroparin Calcium, Dalteparin Sodium, Tinzaparin Sodium, Parnaparin Sodium

What are the Type segmentation covered in the Low Molecular Weight Heparin API Market report?

Ans: The Types covered in the Low Molecular Weight Heparin API Market report are Low Molecular Weight Heparin Sodium, Low Molecular Weight Heparin Calcium

1 Low Molecular Weight Heparin API Market Overview

1.1 Product Definition

1.2 Low Molecular Weight Heparin API by Type

1.2.1 Global Low Molecular Weight Heparin API Market Value Comparison by Type (2024-2030)

1.2.2 Low Molecular Weight Heparin Sodium

1.2.3 Low Molecular Weight Heparin Calcium

1.3 Low Molecular Weight Heparin API by Application

1.3.1 Global Low Molecular Weight Heparin API Market Value by Application (2024-2030)

1.3.2 Enoxaparin Sodium

1.3.3 Nadroparin Calcium

1.3.4 Dalteparin Sodium

1.3.5 Tinzaparin Sodium

1.3.6 Parnaparin Sodium

1.4 Global Low Molecular Weight Heparin API Market Size Estimates and Forecasts

1.4.1 Global Low Molecular Weight Heparin API Revenue 2019-2030

1.4.2 Global Low Molecular Weight Heparin API Sales 2019-2030

1.4.3 Global Low Molecular Weight Heparin API Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Low Molecular Weight Heparin API Market Competition by Manufacturers

2.1 Global Low Molecular Weight Heparin API Sales Market Share by Manufacturers (2019-2024)

2.2 Global Low Molecular Weight Heparin API Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Low Molecular Weight Heparin API Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Low Molecular Weight Heparin API, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Low Molecular Weight Heparin API, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Low Molecular Weight Heparin API, Product Type & Application

2.7 Global Key Manufacturers of Low Molecular Weight Heparin API, Date of Enter into This Industry

2.8 Global Low Molecular Weight Heparin API Market Competitive Situation and Trends

2.8.1 Global Low Molecular Weight Heparin API Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Low Molecular Weight Heparin API Players Market Share by Revenue

2.8.3 Global Low Molecular Weight Heparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Low Molecular Weight Heparin API Market Scenario by Region

3.1 Global Low Molecular Weight Heparin API Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Low Molecular Weight Heparin API Sales by Region: 2019-2030

3.2.1 Global Low Molecular Weight Heparin API Sales by Region: 2019-2024

3.2.2 Global Low Molecular Weight Heparin API Sales by Region: 2025-2030

3.3 Global Low Molecular Weight Heparin API Revenue by Region: 2019-2030

3.3.1 Global Low Molecular Weight Heparin API Revenue by Region: 2019-2024

3.3.2 Global Low Molecular Weight Heparin API Revenue by Region: 2025-2030

3.4 North America Low Molecular Weight Heparin API Market Facts & Figures by Country

3.4.1 North America Low Molecular Weight Heparin API Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Low Molecular Weight Heparin API Sales by Country (2019-2030)

3.4.3 North America Low Molecular Weight Heparin API Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Low Molecular Weight Heparin API Market Facts & Figures by Country

3.5.1 Europe Low Molecular Weight Heparin API Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Low Molecular Weight Heparin API Sales by Country (2019-2030)

3.5.3 Europe Low Molecular Weight Heparin API Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Low Molecular Weight Heparin API Market Facts & Figures by Region

3.6.1 Asia Pacific Low Molecular Weight Heparin API Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Low Molecular Weight Heparin API Sales by Region (2019-2030)

3.6.3 Asia Pacific Low Molecular Weight Heparin API Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Low Molecular Weight Heparin API Market Facts & Figures by Country

3.7.1 Latin America Low Molecular Weight Heparin API Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Low Molecular Weight Heparin API Sales by Country (2019-2030)

3.7.3 Latin America Low Molecular Weight Heparin API Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Low Molecular Weight Heparin API Market Facts & Figures by Country

3.8.1 Middle East and Africa Low Molecular Weight Heparin API Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Low Molecular Weight Heparin API Sales by Country (2019-2030)

3.8.3 Middle East and Africa Low Molecular Weight Heparin API Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Low Molecular Weight Heparin API Sales by Type (2019-2030)

4.1.1 Global Low Molecular Weight Heparin API Sales by Type (2019-2024)

4.1.2 Global Low Molecular Weight Heparin API Sales by Type (2025-2030)

4.1.3 Global Low Molecular Weight Heparin API Sales Market Share by Type (2019-2030)

4.2 Global Low Molecular Weight Heparin API Revenue by Type (2019-2030)

4.2.1 Global Low Molecular Weight Heparin API Revenue by Type (2019-2024)

4.2.2 Global Low Molecular Weight Heparin API Revenue by Type (2025-2030)

4.2.3 Global Low Molecular Weight Heparin API Revenue Market Share by Type (2019-2030)

4.3 Global Low Molecular Weight Heparin API Price by Type (2019-2030)

5 Segment by Application

5.1 Global Low Molecular Weight Heparin API Sales by Application (2019-2030)

5.1.1 Global Low Molecular Weight Heparin API Sales by Application (2019-2024)

5.1.2 Global Low Molecular Weight Heparin API Sales by Application (2025-2030)

5.1.3 Global Low Molecular Weight Heparin API Sales Market Share by Application (2019-2030)

5.2 Global Low Molecular Weight Heparin API Revenue by Application (2019-2030)

5.2.1 Global Low Molecular Weight Heparin API Revenue by Application (2019-2024)

5.2.2 Global Low Molecular Weight Heparin API Revenue by Application (2025-2030)

5.2.3 Global Low Molecular Weight Heparin API Revenue Market Share by Application (2019-2030)

5.3 Global Low Molecular Weight Heparin API Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Yantai Dongcheng Pharmaceutical

6.1.1 Yantai Dongcheng Pharmaceutical Company Information

6.1.2 Yantai Dongcheng Pharmaceutical Description and Business Overview

6.1.3 Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Product Portfolio

6.1.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates

6.2 Shenzhen Hepalink Pharmaceutical

6.2.1 Shenzhen Hepalink Pharmaceutical Company Information

6.2.2 Shenzhen Hepalink Pharmaceutical Description and Business Overview

6.2.3 Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Product Portfolio

6.2.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Company Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Pfizer Low Molecular Weight Heparin API Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Nanjing King-friend Biochemical Pharmaceutical

6.4.1 Nanjing King-friend Biochemical Pharmaceutical Company Information

6.4.2 Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview

6.4.3 Nanjing King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Nanjing King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin API Product Portfolio

6.4.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates

6.5 Changzhou Qianhong Biopharma

6.5.1 Changzhou Qianhong Biopharma Company Information

6.5.2 Changzhou Qianhong Biopharma Description and Business Overview

6.5.3 Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Product Portfolio

6.5.5 Changzhou Qianhong Biopharma Recent Developments/Updates

6.6 Qingdao Jiulong Biopharmaceutical

6.6.1 Qingdao Jiulong Biopharmaceutical Company Information

6.6.2 Qingdao Jiulong Biopharmaceutical Description and Business Overview

6.6.3 Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Product Portfolio

6.6.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates

6.7 Dongying Tiandong Pharmaceutical

6.7.1 Dongying Tiandong Pharmaceutical Company Information

6.7.2 Dongying Tiandong Pharmaceutical Description and Business Overview

6.7.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Product Portfolio

6.7.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates

6.8 Yino Pharma

6.8.1 Yino Pharma Company Information

6.8.2 Yino Pharma Description and Business Overview

6.8.3 Yino Pharma Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Yino Pharma Low Molecular Weight Heparin API Product Portfolio

6.8.5 Yino Pharma Recent Developments/Updates

6.9 Opocrin

6.9.1 Opocrin Company Information

6.9.2 Opocrin Description and Business Overview

6.9.3 Opocrin Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Opocrin Low Molecular Weight Heparin API Product Portfolio

6.9.5 Opocrin Recent Developments/Updates

6.10 Hebei Changshan Biochemical Pharmaceutical

6.10.1 Hebei Changshan Biochemical Pharmaceutical Company Information

6.10.2 Hebei Changshan Biochemical Pharmaceutical Description and Business Overview

6.10.3 Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin API Product Portfolio

6.10.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates

6.11 Hubei Enoray Biopharmaceutical

6.11.1 Hubei Enoray Biopharmaceutical Company Information

6.11.2 Hubei Enoray Biopharmaceutical Description and Business Overview

6.11.3 Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Product Portfolio

6.11.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates

6.12 Nanjing Nanda Pharmaceutical

6.12.1 Nanjing Nanda Pharmaceutical Company Information

6.12.2 Nanjing Nanda Pharmaceutical Description and Business Overview

6.12.3 Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Product Portfolio

6.12.5 Nanjing Nanda Pharmaceutical Recent Developments/Updates

6.13 Cisen Pharmaceutical

6.13.1 Cisen Pharmaceutical Company Information

6.13.2 Cisen Pharmaceutical Description and Business Overview

6.13.3 Cisen Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Cisen Pharmaceutical Low Molecular Weight Heparin API Product Portfolio

6.13.5 Cisen Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Low Molecular Weight Heparin API Industry Chain Analysis

7.2 Low Molecular Weight Heparin API Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Low Molecular Weight Heparin API Production Mode & Process

7.4 Low Molecular Weight Heparin API Sales and Marketing

7.4.1 Low Molecular Weight Heparin API Sales Channels

7.4.2 Low Molecular Weight Heparin API Distributors

7.5 Low Molecular Weight Heparin API Customers

8 Low Molecular Weight Heparin API Market Dynamics

8.1 Low Molecular Weight Heparin API Industry Trends

8.2 Low Molecular Weight Heparin API Market Drivers

8.3 Low Molecular Weight Heparin API Market Challenges

8.4 Low Molecular Weight Heparin API Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Shenzhen Hepalink Pharmaceutical

Yantai Dongcheng Pharmaceutical

Nanjing King-friend Biochemical Pharmaceutical

Pfizer Inc

Hebei Changshan Biochemical Pharmaceutical

Qingdao Jiulong Biopharmaceutical

Changzhou Qianhong Biopharma

Dongying Tiandong Pharmaceutical

Opocrin

Hubei Enoray Biopharmaceutical

Yino Pharma

Cisen Pharmaceutical

NanJing Nanda Pharmaceutical

List of Tables

Table 1. Global Low Molecular Weight Heparin API Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Low Molecular Weight Heparin API Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Low Molecular Weight Heparin API Market Competitive Situation by Manufacturers in 2023

Table 4. Global Low Molecular Weight Heparin API Sales (Billion Units) of Key Manufacturers (2019-2024)

Table 5. Global Low Molecular Weight Heparin API Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Low Molecular Weight Heparin API Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Low Molecular Weight Heparin API Average Price (US$/Billion Untis) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Low Molecular Weight Heparin API, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Low Molecular Weight Heparin API, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Low Molecular Weight Heparin API, Product Type & Application

Table 12. Global Key Manufacturers of Low Molecular Weight Heparin API, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Low Molecular Weight Heparin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin API as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Low Molecular Weight Heparin API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Low Molecular Weight Heparin API Sales by Region (2019-2024) & (Billion Units)

Table 18. Global Low Molecular Weight Heparin API Sales Market Share by Region (2019-2024)

Table 19. Global Low Molecular Weight Heparin API Sales by Region (2025-2030) & (Billion Units)

Table 20. Global Low Molecular Weight Heparin API Sales Market Share by Region (2025-2030)

Table 21. Global Low Molecular Weight Heparin API Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Low Molecular Weight Heparin API Revenue Market Share by Region (2019-2024)

Table 23. Global Low Molecular Weight Heparin API Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Low Molecular Weight Heparin API Revenue Market Share by Region (2025-2030)

Table 25. North America Low Molecular Weight Heparin API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Low Molecular Weight Heparin API Sales by Country (2019-2024) & (Billion Units)

Table 27. North America Low Molecular Weight Heparin API Sales by Country (2025-2030) & (Billion Units)

Table 28. North America Low Molecular Weight Heparin API Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Low Molecular Weight Heparin API Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Low Molecular Weight Heparin API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Low Molecular Weight Heparin API Sales by Country (2019-2024) & (Billion Units)

Table 32. Europe Low Molecular Weight Heparin API Sales by Country (2025-2030) & (Billion Units)

Table 33. Europe Low Molecular Weight Heparin API Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Low Molecular Weight Heparin API Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Low Molecular Weight Heparin API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Low Molecular Weight Heparin API Sales by Region (2019-2024) & (Billion Units)

Table 37. Asia Pacific Low Molecular Weight Heparin API Sales by Region (2025-2030) & (Billion Units)

Table 38. Asia Pacific Low Molecular Weight Heparin API Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Low Molecular Weight Heparin API Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Low Molecular Weight Heparin API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Low Molecular Weight Heparin API Sales by Country (2019-2024) & (Billion Units)

Table 42. Latin America Low Molecular Weight Heparin API Sales by Country (2025-2030) & (Billion Units)

Table 43. Latin America Low Molecular Weight Heparin API Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Low Molecular Weight Heparin API Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Low Molecular Weight Heparin API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Low Molecular Weight Heparin API Sales by Country (2019-2024) & (Billion Units)

Table 47. Middle East and Africa Low Molecular Weight Heparin API Sales by Country (2025-2030) & (Billion Units)

Table 48. Middle East and Africa Low Molecular Weight Heparin API Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Low Molecular Weight Heparin API Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Low Molecular Weight Heparin API Sales (Billion Units) by Type (2019-2024)

Table 51. Global Low Molecular Weight Heparin API Sales (Billion Units) by Type (2025-2030)

Table 52. Global Low Molecular Weight Heparin API Sales Market Share by Type (2019-2024)

Table 53. Global Low Molecular Weight Heparin API Sales Market Share by Type (2025-2030)

Table 54. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Low Molecular Weight Heparin API Revenue Market Share by Type (2019-2024)

Table 57. Global Low Molecular Weight Heparin API Revenue Market Share by Type (2025-2030)

Table 58. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Type (2019-2024)

Table 59. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Type (2025-2030)

Table 60. Global Low Molecular Weight Heparin API Sales (Billion Units) by Application (2019-2024)

Table 61. Global Low Molecular Weight Heparin API Sales (Billion Units) by Application (2025-2030)

Table 62. Global Low Molecular Weight Heparin API Sales Market Share by Application (2019-2024)

Table 63. Global Low Molecular Weight Heparin API Sales Market Share by Application (2025-2030)

Table 64. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Low Molecular Weight Heparin API Revenue Market Share by Application (2019-2024)

Table 67. Global Low Molecular Weight Heparin API Revenue Market Share by Application (2025-2030)

Table 68. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Application (2019-2024)

Table 69. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Application (2025-2030)

Table 70. Yantai Dongcheng Pharmaceutical Company Information

Table 71. Yantai Dongcheng Pharmaceutical Description and Business Overview

Table 72. Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 73. Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Product

Table 74. Yantai Dongcheng Pharmaceutical Recent Developments/Updates

Table 75. Shenzhen Hepalink Pharmaceutical Company Information

Table 76. Shenzhen Hepalink Pharmaceutical Description and Business Overview

Table 77. Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 78. Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Product

Table 79. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates

Table 80. Pfizer Company Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 83. Pfizer Low Molecular Weight Heparin API Product

Table 84. Pfizer Recent Developments/Updates

Table 85. Nanjing King-friend Biochemical Pharmaceutical Company Information

Table 86. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview

Table 87. Nanjing King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 88. Nanjing King-friend Biochemical Pharmaceutical Low Molecular Weight Heparin API Product

Table 89. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates

Table 90. Changzhou Qianhong Biopharma Company Information

Table 91. Changzhou Qianhong Biopharma Description and Business Overview

Table 92. Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 93. Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Product

Table 94. Changzhou Qianhong Biopharma Recent Developments/Updates

Table 95. Qingdao Jiulong Biopharmaceutical Company Information

Table 96. Qingdao Jiulong Biopharmaceutical Description and Business Overview

Table 97. Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 98. Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Product

Table 99. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates

Table 100. Dongying Tiandong Pharmaceutical Company Information

Table 101. Dongying Tiandong Pharmaceutical Description and Business Overview

Table 102. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 103. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Product

Table 104. Dongying Tiandong Pharmaceutical Recent Developments/Updates

Table 105. Yino Pharma Company Information

Table 106. Yino Pharma Description and Business Overview

Table 107. Yino Pharma Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 108. Yino Pharma Low Molecular Weight Heparin API Product

Table 109. Yino Pharma Recent Developments/Updates

Table 110. Opocrin Company Information

Table 111. Opocrin Description and Business Overview

Table 112. Opocrin Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 113. Opocrin Low Molecular Weight Heparin API Product

Table 114. Opocrin Recent Developments/Updates

Table 115. Hebei Changshan Biochemical Pharmaceutical Company Information

Table 116. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview

Table 117. Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 118. Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin API Product

Table 119. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates

Table 120. Hubei Enoray Biopharmaceutical Company Information

Table 121. Hubei Enoray Biopharmaceutical Description and Business Overview

Table 122. Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 123. Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Product

Table 124. Hubei Enoray Biopharmaceutical Recent Developments/Updates

Table 125. Nanjing Nanda Pharmaceutical Company Information

Table 126. Nanjing Nanda Pharmaceutical Description and Business Overview

Table 127. Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 128. Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Product

Table 129. Nanjing Nanda Pharmaceutical Recent Developments/Updates

Table 130. Cisen Pharmaceutical Company Information

Table 131. Cisen Pharmaceutical Description and Business Overview

Table 132. Cisen Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2019-2024)

Table 133. Cisen Pharmaceutical Low Molecular Weight Heparin API Product

Table 134. Cisen Pharmaceutical Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Low Molecular Weight Heparin API Distributors List

Table 138. Low Molecular Weight Heparin API Customers List

Table 139. Low Molecular Weight Heparin API Market Trends

Table 140. Low Molecular Weight Heparin API Market Drivers

Table 141. Low Molecular Weight Heparin API Market Challenges

Table 142. Low Molecular Weight Heparin API Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Low Molecular Weight Heparin API

Figure 2. Global Low Molecular Weight Heparin API Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Low Molecular Weight Heparin API Market Share by Type: 2023 & 2030

Figure 4. Low Molecular Weight Heparin Sodium Product Picture

Figure 5. Low Molecular Weight Heparin Calcium Product Picture

Figure 6. Global Low Molecular Weight Heparin API Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Low Molecular Weight Heparin API Market Share by Application: 2023 & 2030

Figure 8. Enoxaparin Sodium

Figure 9. Nadroparin Calcium

Figure 10. Dalteparin Sodium

Figure 11. Tinzaparin Sodium

Figure 12. Parnaparin Sodium

Figure 13. Global Low Molecular Weight Heparin API Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Low Molecular Weight Heparin API Market Size (2019-2030) & (US$ Million)

Figure 15. Global Low Molecular Weight Heparin API Sales (2019-2030) & (Billion Units)

Figure 16. Global Low Molecular Weight Heparin API Average Price (US$/Billion Untis) & (2019-2030)

Figure 17. Low Molecular Weight Heparin API Report Years Considered

Figure 18. Low Molecular Weight Heparin API Sales Share by Manufacturers in 2023

Figure 19. Global Low Molecular Weight Heparin API Revenue Share by Manufacturers in 2023

Figure 20. Global 5 and 10 Largest Low Molecular Weight Heparin API Players: Market Share by Revenue in Low Molecular Weight Heparin API in 2023

Figure 21. Low Molecular Weight Heparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 22. Global Low Molecular Weight Heparin API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Low Molecular Weight Heparin API Sales Market Share by Country (2019-2030)

Figure 24. North America Low Molecular Weight Heparin API Revenue Market Share by Country (2019-2030)

Figure 25. United States Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Low Molecular Weight Heparin API Sales Market Share by Country (2019-2030)

Figure 28. Europe Low Molecular Weight Heparin API Revenue Market Share by Country (2019-2030)

Figure 29. Germany Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Low Molecular Weight Heparin API Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Low Molecular Weight Heparin API Revenue Market Share by Region (2019-2030)

Figure 36. China Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Low Molecular Weight Heparin API Sales Market Share by Country (2019-2030)

Figure 44. Mexico Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Colombia Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East and Africa Low Molecular Weight Heparin API Sales Market Share by Country (2019-2030)

Figure 49. Middle East and Africa Low Molecular Weight Heparin API Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Low Molecular Weight Heparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Low Molecular Weight Heparin API by Type (2019-2030)

Figure 54. Global Revenue Market Share of Low Molecular Weight Heparin API by Type (2019-2030)

Figure 55. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Type (2019-2030)

Figure 56. Global Sales Market Share of Low Molecular Weight Heparin API by Application (2019-2030)

Figure 57. Global Revenue Market Share of Low Molecular Weight Heparin API by Application (2019-2030)

Figure 58. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Application (2019-2030)

Figure 59. Low Molecular Weight Heparin API Value Chain

Figure 60. Low Molecular Weight Heparin API Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions